Drug Approval And Market ExclusivityThe FDA has granted Orphan Drug Designation for VGT-1849B, which could offer seven-year market exclusivity if approved.
Legal Outcomes And Revenue PotentialA crucial legal win may signal additional upside not factored into forecasts, potentially resulting in HETLIOZ approval for jet lag disorder and unaccounted revenue.
Product Sales And Brand AwarenessFanapt experienced significant growth with total prescriptions increasing by ~24% and Fanapt net product sales rising by 27%, boosted by a direct-to-consumer campaign.